There are over 50 million people worldwide living with dementia and by 2030 this number is expected to reach 82 million. 

The ageing brain becomes vulnerable to decline and keeping independency in daily life can become a challenge for the elderly. People with Mild Cognitive Impairment (MCI), an intermediate condition between normal brain ageing and dementia, may develop dementia in the future.

There is an urgent need for early risk assessment and intervention. Current practices with time-consuming patient investigations focus on late symptoms management  due to a lack of diagnostic tools. This causes numerous implications in terms of familial, medical and care costs. 

With AI-Mind we aim to reduce the disease’s burden by developing novel, AI-based tools to support healthcare professionals in their diagnosis and offering timely interventions to patients.